– About US$ 550 million lifted by portfolio businesses in 2021
– IO Biotech IPO on US NASDAQ
– Forendo Pharma obtained for just about US$ 1 billion
– Muna released with world-main science to progress most up-to-date scientific breakthroughs in neuroscience
– Adcendo elevated US$ 60 million Sequence A to deliver following-generation Antibody-Drug Conjugates
– Hemab elevated US$ 50 million Sequence A to acquire bispecific antibodies for the procedure of rare bleeding conditions
– Novo Seeds expanded its bioindustrials portfolio with Bactolife and 21st Bio
COPENHAGEN, Denmark, Jan. 12, 2022 /PRNewswire/ — Novo Seeds, the early stage investment and company development crew of Novo Holdings, now publishes its review of 2021 – an exceptional yr for enterprise generation and the portfolio. For more information, please see in this article.
Novo Seeds’ dedication to early-stage funding and undertaking creation resulted in an unparalleled amount of capital and curiosity from fellow VCs throughout Europe and the US in 2021, with above US$ 550 million raised by Novo Seeds’ portfolio organizations. Targeted on maximising the prospective of scientific breakthroughs, Novo Seeds ongoing to see an growing range of thrilling financial investment possibilities. Muna Therapeutics, Adcendo and Hemab, a few providers that Novo Seeds helped create, every single elevated sizeable Series A rounds in excessive of US$ 50 million. Meanwhile, 2021 observed the NASDAQ IPO of IO Biotech, a portfolio organization for which Novo Seeds was the 1st trader and continued to be a main investor during the firm’s advancement and progress. Pharma M&A was a big topic in 2021 with portfolio firm, Forendo Pharma, staying obtained by Organon for US$ 954 million, but yet another example of Nordic price development.
Commenting on a hugely profitable calendar year, Søren Møller, Controlling Companion at Novo Seeds, claimed: “2021 has shown the enormous prospective of our industry to translate scientific breakthroughs into greater therapies addressing significant world unmet clinical requirements. Novo Seeds gained a by no means-viewed-ahead of volume of money and fascination from European and US buyers, and we are very pleased to have co-led new investments with extraordinary fellow VCs and to have labored with experts and founders across the most renowned tutorial establishments in the Nordics and all-around the environment.”
“Our ambition proceeds to be to nurture and incubate untapped innovation in the Nordic region and globally, with the intention of constructing and facilitating synergistic collaborations across the lifetime science ecosystem, and we are uniquely positioned to do this. 2021 was definitely a document calendar year and we anticipate a lot more thrilling company creation and substantial developments across our portfolio in 2022.”
Novo Seeds’ knowledge in constructing biotech corporations, alongside one another with its monetary sources, network, and group of business people-in-residence, will make it a person of the major venture creators in Europe. The crew can help build lifestyle science ventures to real inflection factors, attracting international traders to considerable financing rounds and supporting portfolio companies in productive exits.
About Novo Holdings A/S
Novo Holdings A/S is a non-public minimal liability firm wholly owned by the Novo Nordisk Basis. It is the keeping corporation of the Novo Group, comprising Novo Nordisk A/S and Novozymes A/S, and is dependable for controlling the Novo Nordisk Foundation’s property.
Novo Holdings is recognized as a primary intercontinental daily life science investor, with a target on creating lengthy-phrase value. As a daily life science trader, Novo Holdings presents seed and undertaking funds to enhancement-stage organizations and normally takes considerable ownership positions in growth and properly-set up providers. Novo Holdings also manages a wide portfolio of diversified economical belongings. Even more info: www.novoholdings.dk.
View initial information:https://www.prnewswire.com/information-releases/novo-seeds-offers-business-update-on-a-history-calendar year—developing-excellent-organizations-for-world wide-effects-301459252.html
Supply Novo
